Relay Therapeutics Ownership | Who Owns Relay Therapeutics?
Relay Therapeutics Ownership Summary
Relay Therapeutics is owned by 33.58% institutional investors, 1.31% insiders, and 65.11% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 16.29% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.41% of its assets in Relay Therapeutics shares.
RLAY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relay Therapeutics | 33.58% | 1.31% | 65.11% |
| Sector | Healthcare Stocks | 232.51% | 10.72% | -143.23% |
| Industry | Biotech Stocks | 384.56% | 10.58% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sb investment advisers (uk) | 27.90M | 16.29% | $145.66M |
| Commodore capital lp | 17.00M | 9.93% | $88.74M |
| Point72 asset management | 14.77M | 8.63% | $77.12M |
| Blackrock | 10.54M | 7.94% | $68.74M |
| Blackrock funding, inc. /de | 13.23M | 7.67% | $111.91M |
| Casdin capital | 11.34M | 6.62% | $59.20M |
| Vanguard group | 9.69M | 5.62% | $81.99M |
| Bellevue group | 8.35M | 4.87% | $43.56M |
| Tang capital management | 8.07M | 4.71% | $42.12M |
| State street | 5.07M | 2.96% | $26.44M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Casdin capital | 11.34M | 4.94% | $59.20M |
| Commodore capital lp | 17.00M | 4.33% | $88.74M |
| Nextech invest | 3.85M | 3.06% | $20.08M |
| Foresite capital management iv | 1.00M | 2.86% | $5.22M |
| Nextech invest | 3.85M | 2.57% | $15.85M |
| Bioimpact capital | 2.28M | 1.95% | $11.92M |
| Tang capital management | 8.07M | 1.62% | $42.12M |
| Kynam capital management, lp | 2.89M | 1.12% | $15.07M |
| Sb investment advisers (uk) | 27.90M | 1.10% | $145.66M |
| Bellevue group | 8.35M | 0.91% | $43.56M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | 17.00M | 4.33% | 3.65M |
| Tcg crossover management | 1.81M | 0.46% | 1.81M |
| Point72 asset management | 14.77M | 0.13% | 1.33M |
| Norges bank | 837.42K | 0.00% | 837.42K |
| Blackrock | 10.54M | 0.00% | 746.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -3.50M |
| Eventide asset management | - | - | -2.68M |
| Finepoint capital lp | - | - | -2.12M |
| Price t rowe associates inc /md/ | 1.14M | 0.00% | -1.74M |
| Jacobs levy equity management | - | - | -1.68M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 1.81M | 0.46% | 1.81M | $9.45M |
| Norges bank | 837.42K | 0.00% | 837.42K | $7.08M |
| Allianz asset management gmbh | 560.30K | 0.00% | 560.30K | $4.74M |
| Silverarc capital management | 398.17K | 0.47% | 398.17K | $3.37M |
| Connor, clark & lunn investment management | 389.56K | 0.01% | 389.56K | $3.30M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Capital performance advisors llp | -11.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| First command advisory services | -25.00 |
| Massmutual trust co fsb/adv | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 150 | -26.11% | 57,894,103 | -65.17% | 33 | 0.36% | 73 | -15.12% | 39 | -38.10% |
| Sep 30, 2025 | 192 | -3.52% | 164,241,668 | -1.23% | 95 | 1.02% | 79 | -25.47% | 63 | 26.00% |
| Jun 30, 2025 | 203 | -3.33% | 170,787,021 | 4.95% | 99 | 1.08% | 106 | -3.64% | 54 | -5.26% |
| Mar 31, 2025 | 13 | -93.60% | 21,465,711 | -86.91% | 12 | 0.09% | 8 | -93.89% | 2 | -94.44% |
| Dec 31, 2024 | 192 | -3.52% | 130,207,976 | -17.33% | 92 | 0.74% | 123 | 4.24% | 35 | -22.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.38M | 4.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.17M | 3.01% | -114.66K |
| Vanguard US Total Market Shares ETF | 4.89M | 2.88% | 904.00K |
| iShares Russell 2000 ETF | 3.23M | 1.87% | - |
| Eventide Healthcare & Life Sciences I | 2.68M | 1.56% | - |
| JPMorgan Small Cap Growth A | 2.20M | 1.29% | 32.86K |
| SPDR® S&P Biotech ETF | 2.22M | 1.29% | 4.95K |
| Vanguard Small Cap Index | 2.02M | 1.18% | 7.50K |
| Belfius Equities Cure C Cap | 1.73M | 1.02% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.43M | 0.84% | -620.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 27, 2026 | Bergstrom Donald A | President, R&D | Sell | $143.98K |
| Jan 28, 2026 | Bergstrom Donald A | President, R&D | Sell | $22.70K |
| Jan 27, 2026 | Rahmer Peter | See remarks | Sell | $89.03K |
| Jan 28, 2026 | Rahmer Peter | See remarks | Sell | $11.44K |
| Jan 27, 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | $105.31K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 10 |
| 2025 Q2 | - | 12 |
| 2025 Q1 | - | 25 |
RLAY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools